Restriction-modification (RM) systems hinder the use of genetic approaches in the vast majority of bacteria.
12
Restriction-modification (RM) systems are bacterial defense mechanisms that have hampered microbial 13 genetic engineering since the inception of recombinant genetics 40 years ago 1 . Found in ~90% of sequenced 14 bacterial genomes, RM systems enable bacteria to distinguish self from nonself DNA via two enzymatic 15 activities: a restriction endonuclease (REase) and a modification methyltransferase (MTase). The REase 16 recognizes the methylation status of DNA at a highly specific DNA target sequence and degrades 17 unmethylated or inappropriately methylated (i.e., nonself) targets. Its cognate MTase protects the same 18 target sequence across the host's genome via addition of a methyl group, marking each site as self. RM 19 targets vary greatly in sequence and length, typically ranging from 4-18 bp. To date, >450 different target 20 sequences and >4,000 RM-associated enzymes have been identified 2 . Additionally, the number of these 21 systems present in a bacterial cell and the targets recognized are hypervariable and highly species specific, 22 often even strain, specific 3 . 23
Numerous approaches to overcome RM systems have been developed 4 , almost all involve a mimicry-by-24 methylation approach to replicate the specific methylation pattern of the desired bacterial host on human-25 made DNA by using heterologously expressed methyltransferase (MTase) enzymes 5, 6 or, less successfully, 26 crude cell lysates from the strain of interest. Although sometimes effective, mimicry-by-methylation 27 approaches are time, resource, and cost intensive, and they suffer from limited applicability across different 28
strains (Supplementary Note 1). 29
Here we present SyngenicDNA (Supplementary Note 2), a rapid, systematic, and relatively inexpensive 30 approach to circumvent RM barriers during microbial genetic engineering. In contrast to current mimicry-31 by-methylation approaches, SyngenicDNA involves a stealth-by-engineering approach (Supplementary 32 Fig. 1 ). It is inspired by a simple hypothesis: if a synthetic piece of DNA lacks the highly specific target 33 recognition sequences for a host's RM systems, then it is invisible to these systems and will not be degraded 34 during artificial transformation. Therefore, in the SyngenicDNA approach, we identify the precise targets 35 of the RM systems within an intractable (or poorly tractable) bacterial strain, eliminate these targets from 36 the DNA sequence template of a genetic tool in silico-via single nucleotide polymorphisms (SNPs) or 37 synonymous nucleotide modifications, and synthesize a tailor-made version of the tool that is RM-silent 38 with respect to that specific host (Fig. 1 ). This stealth-based approach allows for simple reworking of 39 currently available genetic tools, and DNA parts, to permit them to efficiently operate in bacteria with active 40 RM defenses. Additionally, for effective propagation of the genetic tool, we have repurposed minicircle 41 technology to eliminate components required in Escherichia coli but superfluous in the target host 42 (Supplementary Fig. 2 ). Though not essential, use of minicircle technology reduces the complexity and 43 increases the flexibility of SyngenicDNA. 44
There are four basic steps ( Fig. 1) to produce SyngenicDNA-based genetic tools: 1) target identification, 45
2) in silico tool assembly, 3) in silico sequence adaptation, and 4) DNA synthesis and assembly. Below, we 46 detail each step and illustrate the power of the SyngenicDNA method by applying it to a poorly tractable 47 strain of the human pathogen Staphylococcus aureus (Fig. 2) . 48
Target identification requires the delineation of each methylated site, with single-base resolution, across an 49 entire bacterial genome (i.e., the methylome) and starts with single molecule real-time (SMRT) 7 genome 50 and methylome sequencing. Using methylome data, we delineate each of the recognition motifs protected 51 by the MTases of the host's RM systems and infer the targets recognized and degraded by their cognate 52 Note 3) . This yields a concise list of a host microbes' RM targets to be eliminated 53 from the DNA sequence of the selected genetic tool. 54
REases (Supplementary
In silico tool assembly requires complete annotation of a genetic tool's sequence with respect to plasmid 55 chassis, replication origins, antibiotic resistance cassettes, promoters, repressors, terminators and functional 56 domains to avoid adverse changes to these structures during subsequent adaptation steps. Ideally, a 57 complete and minimalistic genetic tool with previous demonstrable functionality in a genetically tractable 58 strain is used for initial experiments, allowing for subsequent addition of DNA parts to increase 59 functionality after successful transformation is achieved (Supplementary Note 4) . 60
In silico sequence adaptation of the genetic tool is the most crucial step of the SyngenicDNA approach and 61 exploits an intrinsic evolutionary weakness present in all RM systems: their exquisite specificity in target 62 sequence recognition. REases are toxic in the absence of their cognate MTases and consequently seldom 63 deviate from their recognition specificity 8 . Accordingly, in this step, we first screen the complete nucleotide 64 sequence of the genetic tool for the presence of RM targets delineated by SMRTseq. We then recode the 65 nucleotides of each RM target in silico to eliminate the target while preserving the functionality of the 66 sequence. In noncoding regions, targets are removed by SNPs. In coding regions, the sequence of the target 67 is removed using synonymous codon substitution. A single nucleotide switch is generally sufficient to 68 remove RM targets but multiple switches can also be used. The preferential codon bias of the desired host 69 is used to avoid introducing rare or unfavorable codons during the synonymous switch (Supplementary 70 Note 5). Upon complete removal of all RM targets in silico, the adapted DNA sequence is RM silent with 71 respect to the host and ready for de novo DNA synthesis. 72
Synthesis and assembly of RM-silent genetic tools is carried out with commercially available de novo DNA 73 synthesis and standard assembly approaches, ensuring that any laboratory can construct SyngenicDNA 74 tools. During commercial DNA synthesis, polynucleotide sequences are typically cloned onto an E. coli 75 plasmid replicon, which is propagated to yield large amounts of the synthetic DNA. This E. coli replicon is 76 convenient but might include RM targets that could lead to degradation of the overall circular tool after 77 transformation into the host species. We have developed two solutions to this potential issue. One solution 78 is to generate a SyngenicDNA E. coli plasmid backbone for each specific microbial host strain (Fig. 2) . 79 However, in routine applications this will increase costs of SyngenicDNA synthesis and, moreover, the E. 80 coli replicon itself becomes redundant after propagation in E. coli, as it is typically nonfunctional in other 81 bacterial species after transformation. Our alternative solution, therefore, is to remove the E. coli replicon 82 entirely using minicircle DNA technology, rather than recode it. This approach also increases flexibility 83 because the same E. coli replicon can be used to generate tools for multiple different host strains. 84
Minicircles (MCs) are minimalistic circular expression cassettes devoid of a plasmid backbone 9 . These are 85 primarily used in gene therapy applications to drive stable expression of transgenes in eukaryotic hosts 10 .
86
MCs are produced by attaching a parental plasmid (PP) to a transgene cassette; cultivating this construct in 87 an E. coli host grown to high-cell density; inducing construct recombination to form an isolated transgene 88 on a MC and a separate, automatically degraded, PP containing the E. coli replicon; and, finally, purifying 89 isolated MCs by using standard plasmid methods 9 (Supplementary Fig. 2 ). Because any DNA sequence 90
can take the place of the transgene, we first hypothesized that MC technology could be repurposed to carry 91 entire microbial plasmids and facilitate the removal of superfluous E. coli replicons from shuttle vectors.
92
We demonstrated that the incorporation of SyngenicDNA sequences into a PP allowed us to create 93 SyngenicDNA minicircle plasmid (SyMPL) tools. SyMPL tools include replication, selection, and 94 functional domains for operation in a specific non-E. coli host, but lack an E. coli replicon despite being 95 isolated at high concentrations from the MC-producing E. coli strain. In our SyMPL strategy, we attach a 96 synthesized (and assembled) SyngenicDNA tool to the nonSyngenicDNA E. coli PP and propagate this 97 construct in a MC-producing E. coli strain. The induction of MCs via recombination, with concurrent 98 induction of a specific endonuclease that eliminates the PP, allows for easy isolation of a minimalistic 99
SyngenicDNA-based genetic tool ready to transform into the desired host strain (Supplementary Fig. 2 ). 100
Notably, tool propagation in E. coli leads to the addition of methylation signatures on plasmid DNA by 101 innate E. coli MTase enzymes. We demonstrated that this is also true of the MC-producing E. coli host 102 (Supplementary Fig. 3 ). These methylation signatures can activate Type IV restriction systems, which 103 target and degrade methylated DNA motifs, if such systems are present in a desired host strain. Accordingly, 104
to ensure the functionality of our SyMPL approach in a broad range of microbial species, we applied 105 iterative CRISPR-Cas genome engineering 11 ( Supplementary Fig. 4-6 
109
Based on its public health importance, we selected S. aureus JE2, a derivative of the epidemic USA300 110 community-associated methicillin-resistant S. aureus (MRSA) LAC strain 13 to demonstrate proof of 111 principle for our stealth-by-engineering approaches. We first applied our SyngenicDNA approach to the E. 112 coli-S. aureus shuttle vector pEPSA5 ( Fig. 2A-D, Supplementary Fig. 7 ) and generated pEPSA5SynJE2, were processed and mapped to respective reference sequences using the BLASR mapper 29
(https://github.com/PacificBiosciences/blasr) and the Pacific Biosciences' SMRTAnalysis pipeline 30 (https://www.pacb.com/documentation/smrt-pipe-reference-guide/) using the standard mapping protocol.
31
Interpulse durations were measured and processed for all pulses aligned to each position in the reference 32 sequence. To identify modified positions, we used Pacific Biosciences' SMRTanalysis v2.3.0 patch 5, 33 which uses an in silico kinetic reference and a t-test-based kinetic score detection of modified base 34 positions. Using SMRTseq data, RM system identification was performed essentially as previously 35 described 3 , using the SEQWARE computer resource, a BLAST-based software module in combination with 36 the curated restriction enzyme database (REBASE) 4 . Prediction was supported by sequence similarity, 37 presence, and order of predictive functional motifs, in addition to the known genomic context and 38 characteristics of empirically characterized R-M system genes within REBASE and enabled the reliable 39 assignment of candidate methyltransferase genes to each specificity based on their RM types. 40
Bioinformatics and SyngenicDNA adaptation in silico 41
DNA sequence analysis and manipulation was performed using the Seqbuilder and Seqman programs of 42 the DNASTAR software package (DNASTAR, Madison, WI). Codon usage analyses and synonymous 43 substitutions were determined using a combination of CodonW and the Codon Usage Database 44 (www.kazusa.or.jp/codon/), and introduced within Seqbuilder to maintain the amino acid integrity of 45 coding regions within E. coli. Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) was used to align 46 DNA and amino acid sequences from original ORFs and SyngenicDNA variants. Plasmid DNA (dsDNA) 47 conversions from weight (µg) to molarity (pmol) was performed with Promega BioMath Calculators 48 (https://www.promega.com/a/apps/biomath/). 49
DNA synthesis and assembly of SyngenicDNA plasmids 50
A SyngenicDNA-variant of the pEPSA5 plasmid (pEPSA5Syn) was assembled by replacing a 3.05 kb 51 fragment of the original plasmid, encompassing three JE2 RM target sites, with a de novo synthesized DNA 52 fragment that was RM-silent with respect to S. aureus JE2 (Fig. 2, Supplementary Fig.7 ). Primers used 53 are listed in Supplementary Table 1 . The original pEPSA5 plasmid was used as the amplification template 54 for the unmodified backbone, while the plasmid pKan-Frag (Synbio Technologies) was used to amplify the 55 modified RM-silent fragment. PCR amplicons were treated with DpnI to digest non-amplified template 56 DNA and the pEPSA5SynJE2 plasmid was assembled using Gibson cloning. Plasmid nucleotide integrity 57 was confirmed by resequencing. The pEPSA5 and pEPSA5SynJE2 plasmids were propagated within E. 58
coli NEBalpha (dam+, dcm+, hsdM+) to produce methylated plasmid DNA or E. coli ER2796 (dam-, dcm-59
, hsdM-) to produce methylation-free plasmid DNA for evasion of Type IV RM systems. Methylation status 60 of plasmid DNA was confirmed by DpnI treatment and agarose gel electrophoresis whereby only 61 methylated plasmids were subject to digestion. 62
Constructing an anhydrotetracycline inducible CRISPR-Cas9/λ-Red gene editing system 63
We utilized a CRISPR-Cas9/λ-Red multigene editing strategy to introduce scarless MTase gene deletions 64
in the E. coli MC strain (ZYCY10P3S2T). This strategy, initially described 5 by Jiang et al., uses a two-65 plasmid system, pCas and pTarget ( Supplementary Fig. 4A ). In the original system, the pCas plasmid 66 maintains a constitutively expressed cas9 gene and an arabinose-inducible regulatory promoter/repressor 67 module (araC-Pbad) controlling the λ-Red system (Gam, Beta, Exo), both present on a temperature sensitive 68 replicon (repA101Ts). The compatible pTarget plasmid has a sgRNA scaffold for the desired Cas9-target 69 under control of the constitutive promoter (J23119) and a pMB1 origin of replication. 70
However, since MC formation within the E. coli MC strain is also regulated by chromosomally integrated 4B). The plasmid pCKTRBS served as template DNA for amplification of the TetR/PtetO module, which 78 was spliced to an 11.3-kb amplicon of pCas (lacking the arabinose module) using Gibson assembly to form 79 pCasTet-λ. The modified pCasTet-λ plasmid, in combination with the original pTarget, allowed for 80 CRISPR-Cas9/λ-Red recombineering using anhydrotetracycline, a derivative of tetracycline that exhibits 81 no antibiotic activity, instead of arabinose as an inducer molecule. 82
Genome editing of E. coli MC strain 83
The E. coli MC strain contains three active MTases (Dcm+, Hsd+, Dam+) encoded by the dcm, hsdMS, and 84 dam genes respectively. To create a suite of E. coli MC strains, each capable of producing MCs with 85 different methylation signatures, we sequentially deleted (in three-rounds) these MTase genes from the E. 86 coli MC genome using our modified anhydrotetracycline-inducible CRISPR-Cas9/λ-Red recombineering 87 strategy ( Supplementary Fig. 4-6) . In this strategy, λ-Red mediated recombination with a DNA editing 88 template eliminates the MTase gene from the chromosome, followed by CRISPR-Cas9 mediated targeting 89 of the MTase gene in unedited cells. Double-stranded DNA breaks introduced by CRISPR/Cas9 are toxic 90 in bacteria, so only cells for which the target sequences have been edited can survive, allowing for positive 91 selection of recombination events. MTase deletion template plasmids were constructed by assembling PCR 92 amplicons of regions 5' and 3' of each MTase (reflecting the desired deletion event) onto a pRRS plasmid 93 backbone (Supplementary Fig. 4C ). These pRRS-based template plasmids were then used to PCR amplify 94 linear editing templates for λ-Red recombineering. To remove template plasmid-carryover during 95 electrotransformation, editing template amplicons were DpnI treated and PCR purified prior to use. 96 E. coli MC competent cells (System Biosciences) were first transformed with pCasTet-λ to form E. coli 97 JMC, which constitutively expressed the Cas9 protein but lacked a gRNA target (Supplementary Fig. 5 ).
98
JMC electrocompetent cells (harboring pCasTet-λ) were generated as previously described 6 . For λ-Red 99 induction of JMC cells, anhydrotetracycline (200 ng/ml; ~0.5 µM) was added to the growing (30°C) culture 100 30 min prior to making cells competent, as described for the arabinose-based system 6 . 
dam-). 124
After each round of genome editing, the phenotypic effect of dcm, hsdM, and dam gene deletions were 125 confirmed using bisulfite sequencing, SMRTseq, and methyl-dependent restriction enzyme analysis, 126 respectively ( Supplementary Fig. 6 ). Site directed bisulfite sequencing and DpnI methyl-dependent 127 restriction analysis of gDNA were performed essentially as we described previously 7 . 128
Production of SyMPL tools. 129
The 4.3 kbp S. aureus replicon of both pEPSA5 plasmids (pEPSA5 and the pEPSA5SynJE2) were PCR 130 amplified and spliced to the MC parental plasmid (pMC; Systems Biosciences) to form pEPSA5P and 131 pEPSA5SynJE2P (P denotes parental). Primers listed in Supplementary For electroporation, a single aliquot was utilized for each individual experiment for accurate comparison of 157 transformation efficiency between plasmids. The aliquot was thawed on ice for 5 min, transferred to room 158 temperature for 5 min, centrifuged at 5000 x g for 1 min and resuspended in 250 μl sterile electroporation 159 buffer (10% glycerol, 500 mM sucrose). A 50 µl volume of competent cells was mixed with 1 µg plasmid 160 DNA (250 ng/ul in sterile water) and added to a sterile 1mm-gap electroporation cuvette. The cells were 161 pulsed once using a Bio-Rad Gene Pulser System (settings: 25 μF, 100 Ω, 2.1 kV with a 2.3 millisec time 162 constant) and outgrown in 1 ml of trypic soy broth with 500 mM sucrose for 1 hour at 37°C, diluted for 163 spreading on trypic soy agar plates with 15 µg/ml Cm and incubated overnight at 37°C. 164
Scientific Rigor and Experimental Design. 165
Transformation efficiencies (presented in Figure 2 D 
Supplementary Note 1 1
Numerous approaches have been developed in attempts to overcome the restriction-modification (RM) 2 barriers and each of these provides evidence that circumvention of RM systems can lead to genetic 3 tractability in bacteria [1] [2] [3] [4] [5] [6] [7] [8] . These can all be referred to as mimicry-by-methylation approaches, as they 4 essentially seek to modify the methylation pattern of a genetic tool to match the desired host and achieve 5 molecular mimicry. Such approaches can be categorized as either unrefined or sophisticated, and each has 6 a distinct disadvantage 9 , including being arduous, resource intensive, or requiring many years to develop. 
Supplementary Note 2 31
SyngenicDNA is an intentionally broad term. The word syngenic (also syngeneic) is used in immunology 32 to mean sufficiently identical and immunologically compatible as to allow for transplantation without 33
provoking an immune response. It is usually applied in the context of eukaryotic cell or tissue 34 transplantation in cases where the donor and the recipient are identical twins 23 . Syngenic transplants are the 35 easiest because the identical recipient's immune system readily accepts the graft without risk of rejection. 36 Accordingly, we coined the term 'SyngenicDNA' and define it as a piece of synthetic DNA that has been 37 engineered with sufficient sequence and epigenetic compatibility to allow it to function as self within a 38 specific bacterial host, upon artificial transformation, and be accepted by its RM defenses, i.e., the bacterial 39 innate immune system 24 . 40
Supplementary Note 3 41
Post-replicative modification of DNA by MTases in bacteria results in three types of epigenetic markers: 42 N6-methyladenine (m6A), N4-methylcytosine (m4C), and 5-methylcytosine (m5C)
22
. The complete set of 43 methylations across a bacterial genome is termed the methylome. Currently, efficient methylome analysis 44 can only be accomplished by using single molecule real-time sequencing (SMRTseq; www.pacb.com) 25 .
45
During SMRTseq, a polymerase adds fluorescently labelled bases to a DNA template while the sequencing 46 instrument records both the sequence of bases added and the kinetic information (milliseconds) between 47 successive additions, forming a sequencing trace. DNA templates containing a methylated base cause the 48 polymerase to stall at those sites, leading to a delay in the sequence trace. This kinetic information is used 49 to identify the specific sites of methylation in genomic DNA (m6A, m4C or m5C) based on their 50 characteristic trace 25 . SMRTseq analysis software summarizes the exact sequence of the methylated motifs, 51 the number of motifs present on the genome and the percentage of motifs that are methylated. 52 Accordingly, during the target identification step within the SyngenicDNA approach, we use SMRTseq-53 generated methylome data to identify active RM systems and then infer the specific target recognized by 54 the REase of each system. In a bacterial genome, a methylated motif represents either A) an RM system's 55 target recognition sequence methylated by an MTase to protect the site from its cognate REase, or B) a 56 modification introduced by an orphan MTase, which lacks a cognate REase and may be involved in 57 regulatory activity 26 . To differentiate between these two possibilities, we first evaluate the quantitative 58 SMRTseq methylome data. An active RM system methylates 100% of its target motifs in the genome, 59
because unmethylated motifs are substrates for the cognate REase, which introduces chromosomal breaks 60 resulting in bacterial cell death 27, 28 . Therefore, allowing for a small margin of incomplete post-replicative 61 methylation in actively dividing cells during DNA isolation, we assume that motifs that are methylated 62 >95% indicate an active RM system (Supplementary Fig. 3A) 
Supplementary Note 4 69
The SyngenicDNA approach is most readily applicable to genetic tools that are functional in tractable 70 bacterial strains, to modify them for use in strains that are currently intractable or poorly tractable due to 71 RM barriers (Figure 2) 
be/). 97

Supplementary Note 5 98
The frequency with which an RM target occurs in the DNA sequence of a genetic tool depends on the length 99 and base composition (GC vs AT content) of the target motif. AGCCGCC of the Bpe137I system 19 ). Type I-III RM system targets that occur within non-coding regions 111 can be eliminated readily using single nucleotide polymorphisms (SNPs), whereas those that occur in 112 coding regions require synonymous codon switches (Fig. 2B) . 113
Many genetic tools are dual host-range plasmids (i.e., shuttle vectors) composed of two different functional 114 replicons (origin of replication and accessory genes) permitting them to operate in multiple bacterial species 115 (usually a laboratory strain of E. coli and another desired host species). The activity of the two replicons is 116 usually partitioned depending on the bacterial host strain. The E. coli replicon is active when propagating 117 the genetic tool in E. coli while the other replicon remains inactive until transferred to the desired host 118 strain, whereupon the E. coli replicon then becomes inactive. 119
Notably, bacteria use synonymous codons at unequal frequencies, with some favored over others by natural 120 selection for translation efficiency and accuracy, known as codon bias 38 . Therefore, to avoid the 121 introduction of rare or unfavorable codons when eliminating RM targets within a genetic tool in silico, it is 122 critical to distinguish on which replicon each target motif is present and introduce synonymous substitutions 123 corresponding to the codon bias of that specific host. Codon bias is determined by annotation and analysis 124 of the host's genome generated by SMRTseq. For example, the pEPSA5 plasmid 39 is an E. coli-S. aureus 125 shuttle vector containing a 2.5 kb E. coli replicon (ampicillin-resistance gene and low copy number p15a 126 origin for autonomous replication) and a 4.3 kb S. aureus replicon (chloramphenicol-resistance gene, 127 pC194-derived origin, and a xylose repressor protein gene, xylR) (Supplementary Fig. 2B) As such, the systematic identification of the specific RM barriers present within a bacterial host facilitates 157 the development of a tailored stealth-by-engineering stratagem to evade these barriers during genetic 158 engineering. Once developed, this stratagem can then be reapplied to create additional SyngenicDNA based 159 genetic tools for the same host strain. 160
Supplementary Note 6 161
The majority of laboratory E. coli strains, including the MC producing E. coli host used in this study, 162 contain three active MTases (Dam, Dcm, and HsdM) that introduce methylation modifications to specific 163 target sites on the host genome (Supplementary Fig. 3 ). The Dam MTase modifies the adenine residue 164 ( m6 A) within the sequence GATC, the Dcm MTase modifies the internal cytosine residue ( m5 C) of the 165 sequence CCWGG (where W is A or T), and the HsdM MTase modifies the internal adenine residue ( m6 A) 166 of the sequence AACN6GTGC. Therefore, plasmid tools propagated within such E. coli strains, including 167 the minicircle (MC)-producing strain (ZYCY10P3S2T), are modified at these targets sequences. 168
The presence of methylated sites on SyngenicDNA-based tools could activate Type IV RM systems upon 169 artificial transformation. Generally, unintentional activation of Type IV systems is avoided by the 170 propagation of plasmids within methyl-deficient E. coli strains such as JM110 (dam-, dcm-, hsdRMS+) or 171 ER2796 (dam-, dcm-, hsdRMS-), thus preventing recognition and degradation via these systems. However, 172 such methyl-free E. coli strains are unable to produce MCs since construction of the E. coli MC-producing 173 strain 42 required complex engineering to stably expresses a set of inducible minicircle-assembly enzymes 174
(the øC31-integrase and the I-SceI homing-endonuclease for induction of MC formation and degradation 175 of the parental plasmid replicon, respectively). Accordingly, when we repurposed MC technology for 176 bacterial applications, it was also necessary to engineer E. coli MC producer strains that generates various 177 forms of methylation-free MCs. 178
Although a completely methylation-free MC producer could be required when working against Type IV 179 systems targeting both adenine-and cytosine-methylated DNA, bacterial RM systems exist with targets that 180 specifically match the E. coli Dam MTase motif (GATC), such as the Dpn system of Streptococcus 181 pneumoniae 43 or the Pin25611FII system of Prevotella intermedia
22
. These systems digest unmethylated 182
Dam sites on genetic tools propagated within a completely methyl-free strain, hence Dam methylation is 183 protective in these cases. Therefore, we created a suite of E. coli strains capable of producing distinct types 184 of methyl-free MC DNA ( Supplementary Fig. 4-6 ) to account for the inherent variation of RM systems in 185 bacteria and maximize the applicability of our SyMPL approach, 186
We applied iterative CRISPR-Cas9 genome editing to sequentially delete MTase genes from the original 187 E. coli MC producer strain (dam+, dcm+, hsdM+) ( Supplementary Fig. 4-6) . These new strains produce 188 methylcytosine-free MC DNA (E. coli JMC1; dam+, dcm-, hsdM+), methylcytosine-and methyladenine-189 free MC DNA except for Dam methylation (E. coli JMC2; dam+, dcm-, hsdM-), and completely methyl-190 free MC DNA (E. coli JMC3; dam-, dcm-, hsdM-) . Depending upon the Type IV RM systems identified 191 within a desired bacterial host, one of these strains can be selected and utilized for production of SyMPL 192 tools. 193
Supplementary Note 7 194
By definition, an entirely SyngenicDNA plasmid is silent with respect to all (Type I, II, III, and IV) RM 195 systems within a host strain and is designed to maximize transformation efficiency. C) where S is C or 200 G ( Fig. 2A) . Plasmid tools propagated in E. coli strains containing the Dcm orphan MTase are methylated 201 at C 5m CWGG motifs, which overlap with the SauUSI target motif resulting in vulnerability to degradation 202 by this restriction system upon transformation to S. aureus. Therefore, in addition to the fully SyngenicDNA 203 plasmid (pEPSA5SynJE2Dcm-) we generated partially SyngenicDNA plasmids, one that is RM-silent to 204
Type I systems but not to Type IV systems (pEPSA5SynJE2Dcm+) and another that is vice versa 205 (pEPSA5Dcm-) to determine the relative contribution of Type I or Type IV systems to the genetic barrier 206 in S. aureus JE2. This type of experimental approach can be viewed as a 2x2 factorial design, crossing 207 silencing of the Type I systems and silencing of the Type IV system. 208
The original pEPSA5 plasmid propagated in E. coli NEBalpha, a standard Dcm+ laboratory strain, achieved 209 consistently poor transformation efficiencies in our hands (~10 CFU/µg DNA). This plasmid contains 11 210 individual RM target motifs (Type I; n=3, and Type IV; n=8, Supplementary Fig. 7A ). Both system types 211 are known to be actively involved in defense from foreign DNA in S. aureus 7, 44-46 . Elimination of only 212
Type I target motifs from the plasmid (pEPSA5SynJE2Dcm+) achieved a 13-fold increase (p= 2.75x10
in transformation efficiency. In contrast, elimination of only Type IV system targets, by passaging pEPSA5 214 through the Dcm-deficient strain E. coli ER2796 (pEPSA5Dcm-), achieved a >139-fold increase 215 (p=2.48x10 -69 ) in efficiency. However, when both Type I and Type IV targets were eliminated 216 (pEPSA5SynJE2Dcm-), we observed a supra-multiplicative (rather than an additive) effect on 217 transformation efficiency, with in an increase of ~70,000-fold (p=7.76x10
-306
) compared with the original 218 pEPSA5Dcm+ plasmid (p for interaction=6.98x10 -27 ). The mechanism of this supra-multiplicative effect is 219 not immediately apparent and raises questions for future studies. For example, are there direct interactions 220 between the distinct types of systems? Additionally, comparing the original and the SyngenicDNA pEPSA5 221 plasmids independently of the Type IV system (pEPSA5Dcm-and pEPSA5SynJE2Dcm-) showed that 222 elimination of the three Type I system targets achieved ~500-fold increase (p=<1.0x10 -306 ) in efficiency 223 (Fig. 2B) . As demonstrated here, by using system-specific sets of partially RM-silent plasmids, we can 224 detect the relative contributions of different RM systems within a host strain. 225
Supplementary Note 8 226
We used the dcm-strains E. coli ER2796 and E. coli JMC1 to carry out the minicircle (MC) experiments 227 independently of the Type IV system in S. aureus JE2. The majority of the S. aureus JE2 RM system targets 228 present on pEPSA5 are in the E. coli replicon (Type I; n=2, and Type IV; n=8) with only a single Type I 229 system target in the S. aureus replicon (Supplementary Fig. 7A ), thus the MC approach eliminates 2 of 230 the 3 Type I targets. The focus here was on investigating 1) whether the SyMPL approach achieves equal 231 or perhaps even greater efficiency than the SyngenicDNA approach, 2) whether removal of all Type I 232 targets is required to achieve appreciable gains in transformation efficiency (compared with a partially 233
SyngenicDNA plasmid that has a single Type I target remaining), and 3) whether removing all Type I 234 targets adds further gains in transformation efficiency compared with leaving a single Type I target intact. Fig. 9 ). 244
On a CFU/pmol DNA basis, the MC variant pEPSA5MCDcm-achieved a 436-fold increase in 245 transformation efficiency over the original plasmid pEPSA5Dcm-(p=<1.0x10 -306 ). This increase could be 246 due to the elimination of the two Type I target motifs along with the E. coli replicon in the MC variant 247 (Supplementary Fig. 8 ), the smaller MCs passing more readily through the reversible pores formed in the 248 S. aureus cell envelope during electroporation, or a combination of both. The mere 2.3-fold (p=1.29x10 -4 ) 249 increase in transformation efficiency achieved by MC variant pEPSA5SynJE2MC over the plasmid 250 pEPSA5SynJE2, both of which are completely RM-silent in JE2, favors the first possibility. 251
In contrast, pEPSA5MC and pEPSA5SynJE2MC differed only by the presence or absence of a single Type 252 I target, respectively (Supplementary Fig. 7A ). 
